Jingwen Yao

Title(s)Assistant Professor, Radiological Sciences
SchoolMedicine
ORCID ORCID Icon0000-0002-8828-1841 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, San Francisco, CAPostdoc12/2022Radiology and Biomedical Imaging
    University of California, Los Angeles, Los Angeles, CAPh.D.03/2021Bioengineering
    University of California, Los Angeles, Los Angeles, CAM.S.05/2017Chemistry and Biochemistry
    Shanghai Jiao Tong University, Shanghai, ChinaM.B.B.S.07/2015Clinical Medicine
    Collapse Awards and Honors
    University of California2022UC Chancellor's Postdoctoral Fellowship

    Collapse Overview 
    Collapse Overview
    Dr. Jingwen Yao is an Assistant Professor in the Department of Radiological Sciences at UCLA and a faculty member of the Physics & Biology in Medicine graduate program. She earned her M.B.B.S. in China and completed her Ph.D. in Bioengineering at UCLA, followed by postdoctoral training at UCSF. Dr. Yao's research is centered on developing advanced MRI techniques for applications in brain tumors and other neurological diseases. She is particularly interested in developing and validating MRI biomarkers that reflect physiological and pathological tissue properties for disease progression monitoring and treatment effect assessment.

    Dr. Yao’s current research includes (1) developing and validating imaging biomarkers sensitive to the brain tumor microenvironment, such as tissue acidity, immune infiltration, and tumor vasculature, (2) developing and applying advanced imaging for pathophysiological characterization and treatment targeting in movement disorders. Her research encompasses various aspects of biomarker development, including sequence development, image acquisition and reconstruction, post-processing, quantitative image analysis, and clinical translation and evaluation.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease. Neuroimage. 2023 01; 265:119788. Yao J, Morrison MA, Jakary A, Avadiappan S, Chen Y, Luitjens J, Glueck J, Driscoll T, Geschwind MD, Nelson AB, Villanueva-Meyer JE, Hess CP, Lupo JM. PMID: 36476567.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors. NMR Biomed. 2023 06; 36(6):e4785. Cho NS, Hagiwara A, Yao J, Nathanson DA, Prins RM, Wang C, Raymond C, Desousa BR, Divakaruni A, Morrow DH, Nghiemphu PL, Lai A, Liau LM, Everson RG, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 35704275.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    3. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2022 06 01; 24(6):1020-1028. Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Prins RM, Cloughesy TF, Ellingson BM. PMID: 34865129; PMCID: PMC9159421.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    4. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study. Cancers (Basel). 2022 May 20; 14(10). Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35626127; PMCID: PMC9139712.
      View in: PubMed   Mentions: 1  
    5. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Front Oncol. 2022; 12:849993. Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. PMID: 35371980; PMCID: PMC8964348.
      View in: PubMed   Mentions: 1  
    6. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI. Sci Rep. 2022 01 20; 12(1):1078. Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35058510; PMCID: PMC8776874.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021; 32:102882. Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 34911188; PMCID: PMC8609049.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging. Sci Rep. 2021 07 22; 11(1):15011. Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A. PMID: 34294864; PMCID: PMC8298590.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    9. A study of 3D radial density adapted trajectories for sodium imaging. Magn Reson Imaging. 2021 11; 83:89-95. Bydder M, Ali F, Saucedo A, Hagiwara A, Wang C, Pham AD, Yao J, Ellingson BM. PMID: 34271088.
      View in: PubMed   Mentions:    Fields:    
    10. Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas. J Neurooncol. 2021 May; 152(3):573-582. Tatekawa H, Uetani H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. PMID: 33704629; PMCID: PMC8221401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Detection of cerebral reorganization associated with degenerative cervical myelopathy using diffusion spectral imaging (DSI). J Clin Neurosci. 2021 Apr; 86:164-173. Wang C, Holly LT, Oughourlian T, Yao J, Raymond C, Salamon N, Ellingson BM. PMID: 33775321; PMCID: PMC8007933.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. A physical phantom for amine chemical exchange saturation transfer (CEST) MRI. MAGMA. 2021 Aug; 34(4):569-580. Yao J, Yao J, Wang C, Raymond C, Bergstrom B, Chen X, Das K, Dinh H, Kim ZS, Le AN, Lim MWJ, Pham JAN, Prusan JD, Rao SS, Nathanson DA, Ellingson BM. PMID: 33484366.
      View in: PubMed   Mentions: 1     Fields:    
    13. Minimizing echo and repetition times in magnetic resonance imaging using a double half-echo k-space acquisition and low-rank reconstruction. NMR Biomed. 2021 04; 34(4):e4458. Bydder M, Ali F, Ghodrati V, Hu P, Yao J, Ellingson BM. PMID: 33300182; PMCID: PMC7935763.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas. Neuroradiology. 2021 Jun; 63(6):857-868. Oughourlian TC, Yao J, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 33106922; PMCID: PMC8071834.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. 2020 10 15; 87(5):931-938. Patel KS, Everson RG, Yao J, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32365185; PMCID: PMC7566341.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    16. Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast. Magn Reson Med. 2021 02; 85(2):1062-1078. Yao J, Yao J, Wang C, Ellingson BM. PMID: 32936483; PMCID: PMC8258865.
      View in: PubMed   Mentions: 2     Fields:    
    17. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. J Neurooncol. 2020 Sep; 149(2):337-346. Tatekawa H, Hagiwara A, Uetani H, Yao J, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32929644; PMCID: PMC7682113.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Sci Rep. 2020 09 09; 10(1):14819. Patel KS, Yao J, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 32908231; PMCID: PMC7481206.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    19. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study. Sci Rep. 2020 07 17; 10(1):11922. Yao J, Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32681084; PMCID: PMC7367867.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    20. Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes. J Nucl Med. 2021 03; 62(3):319-325. Tatekawa H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32646876; PMCID: PMC8049346.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    21. Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma. Clin Cancer Res. 2020 07 01; 26(13):3135-3144. Ellingson BM, Yao J, Yao J, Raymond C, Nathanson DA, Chakhoyan A, Simpson J, Garner JS, Olivero AG, Mueller LU, Rodon J, Gerstner E, Cloughesy TF, Wen PY. PMID: 32269051; PMCID: PMC8204664.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    22. Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas. J Neurooncol. 2020 Mar; 147(1):135-145. Oughourlian TC, Yao J, Yao J, Schlossman J, Raymond C, Ji M, Tatekawa H, Salamon N, Pope WB, Czernin J, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 31981013; PMCID: PMC7080591.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro Oncol. 2019 09 06; 21(9):1184-1196. Yao J, Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. PMID: 31066901; PMCID: PMC7594567.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    24. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors. Cancer Imaging. 2019 Mar 18; 19(1):14. Chakhoyan A, Raymond C, Chen J, Goldman J, Yao J, Yao J, Kaprealian TB, Pouratian N, Ellingson BM. PMID: 30885275; PMCID: PMC6423873.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. J Neurooncol. 2019 May; 142(3):587-595. Yao J, Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 30806888; PMCID: PMC6482078.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    26. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019 02 26; 9(1):2846. Chakhoyan A, Yao J, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. PMID: 30808879; PMCID: PMC6391482.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    27. pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI). Neuroimage Clin. 2019; 22:101736. Ellingson BM, Yao J, Yao J, Raymond C, Chakhoyan A, Khatibi K, Salamon N, Villablanca JP, Wanner I, Real CR, Laiwalla A, McArthur DL, Monti MM, Hovda DA, Vespa PM. PMID: 30826686; PMCID: PMC6396390.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    28. Improving B0 Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography. 2018 Sep; 4(3):123-137. Yao J, Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 30320212; PMCID: PMC6173788.
      View in: PubMed   Mentions: 15     Fields:    
    29. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol. 2018 Sep; 139(2):399-409. Patel CB, Fazzari E, Chakhoyan A, Yao J, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. PMID: 29679199; PMCID: PMC6092195.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    30. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med. 2018 11; 80(5):1962-1978. Harris RJ, Yao J, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29626359; PMCID: PMC6107417.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    31. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme. Curr Pharm Des. 2015; 21(36):5256-66. Yao J, Yao J, Hsu CH, Li Z, Kim TS, Hwang LP, Lin YC, Lin YY. PMID: 26412354.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    Jingwen's Networks
    Concepts (114)
    Derived automatically from this person's publications.
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _